Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- donanemab
- Persantine (dipyridamole)
Interactions between your drugs
dipyridamole donanemab
Applies to: Persantine (dipyridamole), donanemab
Using donanemab together with blood-thinning or clot-dissolving medications has not been adequately studied. There are some theoretical concerns that combining donanemab and dipyridamole may increase the risk of bleeding in the brain. Talk to your doctor if you have any questions or concerns. Your doctor will do magnetic resonance imaging (MRI) scans before and during your treatment with donanemab as part of monitoring for potential side effects in the brain. You should seek immediate medical attention if you experience signs and symptoms that may suggest more serious treatment complications such as headache, confusion, dizziness, vision changes, nausea, difficulty walking, or seizures. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
dipyridamole food
Applies to: Persantine (dipyridamole)
Caffeine may interfere with the effects of dipyridamole in dilating the arteries. You should avoid caffeine-containing products for at least 24 hours before an imaging procedure involving dipyridamole given by injection. However, no special precaution is necessary if you are taking dipyridamole orally for maintenance.
dipyridamole food
Applies to: Persantine (dipyridamole)
Ask your doctor before using dipyridamole together with caffeine. Using these medications together can decrease the effects of dipyridamole. It is recommended that caffeine including caffeine be avoided for 12 to 24 hours before dipyridamole administration. You may need a dose adjustment or special test if you use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Aricept
Aricept is used to treat mild to severe dementia caused by Alzheimer's disease. Learn about side ...
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Kisunla
Kisunla (donanemab) is used to treat Alzheimer’s disease to help slow down the decline in memory, t ...
Razadyne
Razadyne information from Drugs.com, includes Razadyne side effects, interactions and indications.
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.